English
Current trends in manufacturing for large volume parenteral in the pharmaceutical industry and future scopes
Tarang Patel
Vatsal Patel
Mehul Patel
Umang Shah
Ashish Patel
Swayamprakash Patel
Nilay Solanki
Abstract
The current features of manufacturing of Large Volume Parenteral from receiving the API and excipient to the final dispatch of product addressed many features including, sampling errors, manufacturing errors other controls, and individuals involved in various phases. The pharmaceutical industry nowadays places a greater focus on production-related issues like handling manpower and quality-related problems and implementing systems like Good Manufacturing Practises, and other systems. To reduce reliance on humans and raise the quality of products, future trends and possibilities in automation in various areas like production, quality assurance, and quality controls were discussed in this paper. For the production of an enormous quantity of parentals, the roles and responsibilities of both the manufacturing team and the quality assurance team are crucial. Future manufacturing initiatives can reduce labour expenses while enhancing product quality, nevertheless, they will also encourage more automation research and development.
Keywords:
Large Volume Parenteral, Quality Assurance, Production, Automation, Pharmaceutical industrySimilar Articles
- Diana Dolzhko, Natalia Melnyk, Aleksandra Kruk, Sebastian Granica, Jakub Piwowarski, Traditional use of polar extracts from lavender flowers – systematic review of literature data , Prospects in Pharmaceutical Sciences: Vol. 22 No. 3 (2024)
- Patrycja Słomczyńska, Jakub Młoźniak, Katarzyna Paradowska, Over-the-counter antihistamines in insomnia therapy , Prospects in Pharmaceutical Sciences: Vol. 22 No. 4 (2024)
- Magdalena Tchorzewska, Malwina Kowalik, Adrianna Kuliś, Wioletta Olejarz, MECHANISMS LEADING TO ANGIOGEGNESIS IN CANCERS , Prospects in Pharmaceutical Sciences: Vol. 17 No. 10 (2019)
- Monika Czerwińska, Marta Kuśnierek, Lycium barbarum fruits –phytochemistry and activity of goji berries – from tradition to clinical studies , Prospects in Pharmaceutical Sciences: Vol. 22 No. 3 (2024)
- Mateusz Sobczyk, Mikołaj Porzak, Daria Żuraw, Alicja Sodolska, Paulina Oleksa, Kacper Jasiński, Small intestinal bacterial overgrowth – current, novel and possible future methods of treatment and diagnosis , Prospects in Pharmaceutical Sciences: Vol. 22 No. 2 (2024)
- Grażyna Kubiak-Tomaszewska, Jan Pachecka, Jacek Łukaszkiewicz, Piotr Tomaszewski, MECHANISMS OF RECEPTOR-DEPENDENT REGULATION OF BILE ACID AND XENOBIOTIC METABOLISM. THE ROLE OF CYP3A4 EXPRESSION IN THE SAFETY AND EFFECTIVENESS OF PHARMACOTHERAPY , Prospects in Pharmaceutical Sciences: Vol. 14 No. 9 (2016)
- Grzegorz Nałęcz-Jawecki, WATER ENVIROMENT TOXICITY INVESTIGATED BY BIOASSAYS , Prospects in Pharmaceutical Sciences: Vol. 1 No. 2 (2003)
- Anna Babis, USABILITY OF THE FRUITS OF ROSA SPINOSISSIMA AND ROSA HYBRIDA TO THE PRODUCTION OF TURBID MULTIVITAMIN JUICES , Prospects in Pharmaceutical Sciences: Vol. 2 No. 3 (2004)
- Marta Oleszczuk, NUCLEAR MAGNETIC RESONANCE IN THE STRUCTURAL INVESTIGATION OF BIOMOLECULES: APPLICATION IN THE STUDY OF MODEL HELICAL SYSTEMS , Prospects in Pharmaceutical Sciences: Vol. 4 No. 1 (2006)
- Joanna Stefańska, Adam Huczyński, BIOLOGICAL PROPERTIES OF MONENSIN A , Prospects in Pharmaceutical Sciences: Vol. 6 No. 2 (2008)
You may also start an advanced similarity search for this article.
Details
References
Statistics
Authors
Citation rules
Cited by / Share
Licence
This work is licensed under a Creative Commons Attribution 4.0 International License.